BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  AACC Buzz: Noninvasive Blood or Saliva Tests for Cancer and COVID-19 Are Promising

  Noninvasive tests for colorectal cancer, prostate cancer and COVID-19 were among the highlights of the American Association for Clinical Chemistry meeting September 26-30.

  October 1, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Business

  GSK and Merck Break Up $4 Billion Oncology Collab After Multiple Failures

  The deal’s termination was announced Thursday, months after bintrafusp alfa failed to hit the mark in a Phase II clinical trial as a potential second-line treatment for metastatic biliary tract cancer.

  October 1, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  FDA

  FDA Action Alert: Takeda, ChemoCentryx, Genmab and Seagen, and Avadel

  The U.S. FDA is kicking off the month of October with a number of PDUFA dates and an advisory committee meeting. Read on for more details.

  October 1, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  Merck COVID-19 Antiviral Cuts Death, Hospitalizations in Half

  The Phase III trial on a potential treatment for mild-to-moderate COVID-19 symptoms by Merck and Ridgeback Biotherapeutics showed promise in preventing hospitalizations and death.

  October 1, 2021

   · 

  4 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  BioNTech Doses First Patient with Personalized mRNA Cancer Vaccine

  First COVID-19, now cancer. BioNTech made history when its COVID-19 mRNA vaccine with partner Pfizer became the first ever approved.

  October 1, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Business

  Trio of Biopharmas Generates Over $500 Million for AI, Oncology Innovation

  This week, three global biopharmaceutical companies received over half a billion dollars to support research and development initiatives in the treatment of rare and deadly diseases.

  October 1, 2021

   · 

  3 min read

   · 

  Vanessa Doctor, RN
• 

  Genetown

  Moderna, Thermo Fisher Expand as Life Sciences Sector Continues to Prosper

  Marked by recent announcements of new manufacturing sites, headquarters and job creations, the life science industry continues to thrive despite the COVID-19 pandemic.

  October 1, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Policy

  Appeals Court Supports Catalyst’s Attempt to Overturn FDA Decision

  Catalyst Pharmaceuticals received a positive decision from the 11th Circuit Court of Appeals over a suit against the U.S. FDA’s approval of a competitor’s amifampridine product.

  October 1, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Deals

  Large Acceleron Stakeholder Says Acquisition Price Undervalues Company

  Investment firm Avoro Capital has raised concerns that the $180 per-share price Merck is paying Acceleron Pharma undervalues the rare-disease focused company.

  October 1, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Clinical Catch-Up: September 27-October 1

  It was a busy week for clinical trial news. Here’s a look.

  October 1, 2021

   · 

  13 min read

   · 

  Mark Terry